Inventor · disambiguated record
Jonathan David Roth
Also filed as: ROTH JONATHAN D · ROTH JONATHAN DAVID
8 granted patents·12 pending applications·62 citations·filing 2004–2022
85Inventor score
Files withAMYLIN PHARMACEUTICALS INC5AEGERION PHARMACEUTICALS INC3AMRYT PHARMACEUTICALS INC2AMYLIN PHARMACEUTICALS LLC2ASTRAZENECA PHARMACEUTICALS LP2
Top patents by PatentIndex Score
20 records- 0192US7723471B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted May 25, 2010·18 cites·53 claims
- 0290US8426361B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameLEVY ODILE ESTHER·Filed 2009·Granted Apr 23, 2013·13 cites·6 claims
- 0387US7399744B2Methods for affecting body compositionAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Jul 15, 2008·25 cites·7 claims
- 0482US8394765B2Methods of treating obesity with two different anti-obesity agentsROTH JONATHAN D·Filed 2007·Granted Mar 12, 2013·5 cites·33 claims
- 0579US2023115655A1Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0670US9879063B2Engineered polypeptides having enhanced duration of action and reduced immunogenicityAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·1 cites·14 claims
- 0768US11535659B2Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·8 claims
- 0862US2015231204A1Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 0960US8906849B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Dec 9, 2014·0 cites·8 claims
- 1060US2008176804A1Methods for Affecting Body CompositionAMYLIN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1158US2014066368A1Methods For Affecting Body CompositionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1255US2013274182A1Engineered polypeptides having enhanced duration of actionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1354US2016137709A1Engineered polypeptides having enhanced duration of actionAEGERION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1452US2018305430A1Engineered Polypeptides Having Enhanced Duration of Action and Reduced ImmunogenicityAEGERION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1550US2024189275A1Methods for treating non-alcoholic steatohepatitis with a scd-1 inhibitorLIPIDIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1648US2014256621A1Engineered poypeptides having enhanced duration of action and reduced immunogenicityERICKSON MARY·Filed 2012·Application pending·0 cites
- 1747US2010323955A1Methods for treating obesity and obesity related diseases and disordersAMYLIN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1842US2009156474A1Methods for treating obesity and obesity related diseases and disordersAMYLIN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1928US8748375B2Methods for affecting body composition using amylin agonistsMACK CHRISTINE M·Filed 2010·Granted Jun 10, 2014·0 cites·3 claims
- 2028US2012071401A1Amylin agonist compounds for estrogen-deficient mammalsROTH JONATHAN DAVID·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan David Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →